Markets:

Overview

News

Currencies

International

Treasuries

ResMed Inc. Common Stock (NY:RMD)

229.33 +0.46 (+0.20%)

Streaming Delayed Price Updated: 3:07 PM EDT, Apr 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

18 19 Next >

ResMed Earnings Reflect Increased Demand For Sleep Devices, Performance Indicates Positive Dynamics, Opportunities ↗

August 02, 2024

ResMed reported Q4 2024 revenue of $1.22 billion, driven by strong demand for sleep devices and software services. Gross margin improved significantly due to reduced costs and higher selling prices....

Via Benzinga

ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024

August 01, 2024

From ResMed Inc.

Via GlobeNewswire

ResMed's Options Frenzy: What You Need to Know ↗

July 30, 2024

Via Benzinga

If You Invested $1000 In This Stock 20 Years Ago, You Would Have $16,000 Today ↗

July 26, 2024

Via Benzinga

Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday ↗

July 23, 2024

Via Benzinga

What 6 Analyst Ratings Have To Say About ResMed ↗

July 23, 2024

Via Benzinga

Looking Into ResMed's Recent Short Interest ↗

July 09, 2024

Via Benzinga

Stock Market News From Amazon, Nike, McCormick, and More ↗

July 08, 2024

We also talk with author Nicola Twilley about her new book, "Frostbite: How Refrigeration Changed Our Food, Our Planet, and Ourselves."

Via The Motley Fool

Falling Knives: 3 Stocks Getting the Cold Shoulder From Analysts ↗

July 05, 2024

Uncover key insights on stocks with negative analyst sentiment, including major moves by Alphabet, Nike and ResMed.

Via InvestorPlace

ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024

July 03, 2024

From ResMed Inc.

Via GlobeNewswire

$1000 Invested In This Stock 15 Years Ago Would Be Worth $9,600 Today ↗

July 02, 2024

Via Benzinga

Is NYSE:RMD a Good Fit for Dividend Investing? ↗

July 01, 2024

Uncovering Dividend Opportunities with RESMED INC (NYSE:RMD).

Via Chartmill

Beyond The Numbers: 6 Analysts Discuss ResMed Stock ↗

June 25, 2024

Via Benzinga

(RMD) - Analyzing ResMed's Short Interest ↗

June 20, 2024

Via Benzinga

How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You? ↗

July 02, 2024

We also talk about weight loss drugs and sleep apnea, and other stock market news.

Via The Motley Fool

Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market

July 01, 2024

Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound.

Via MarketBeat

Sound Investments: 3 Stocks to Buy for a Good Night’s Rest ↗

June 29, 2024

The safe stocks to buy for a good night’s rest aren’t the kind you’re thinking about. Nonetheless, they do make worthwhile investments.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

June 26, 2024

Via Benzinga

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $11,000 Today ↗

June 17, 2024

Via Benzinga

(RMD) - Analyzing ResMed's Short Interest ↗

May 27, 2024

Via Benzinga

Why ResMed Shares Are Trading Lower Monday ↗

June 24, 2024

ResMed stock is trading lower Monday after Eli Lilly and Company released data from a clinical trial in regards to the treatment of sleep apnea.

Via Benzinga

ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday ↗

June 24, 2024

Via Benzinga

Semiconductor, Nvidia Woes Deepen; Nasdaq 100 Slips, Dow Rallies; Bitcoin Sinks To $60,400: What's Driving Markets Monday? ↗

June 24, 2024

Wall Street faces a continuation of last week’s trend during Monday’s morning trading, with semiconductor stocks selling off heavily and dragging down the tech sector, while the broader market remains...

Via Benzinga

Topics Stocks

Stocks Mixed As Investors Take Big Tech Profits ↗

June 24, 2024

The major benchmarks are mixed today, as investors cycle out of the outperforming tech sector and buy into bank and energy stocks.

Via Talk Markets

Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again ↗

June 24, 2024

Eli Lilly tested its weight-loss drug in people with obesity suffering from sleep apnea events.

Via Investor's Business Daily

Nasdaq Futures Slip As Nvidia Sell-Off Continues, S&P 500 Futures Hold Up: Analyst Says 'Valuations Will Go Parabolic And It Will Be A Perfect Time To Sell' ↗

June 24, 2024

The U.S.

Via Benzinga

Topics Stocks

Elliott Wave Technical Forecast: Unlocking ASX Trading Success: ResMed Inc ↗

June 17, 2024

The analysis aims to provide readers with insights into the current market trends and how to capitalize on them effectively.

Via Talk Markets

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

June 10, 2024

ResMed studies presented at SLEEP 2024 also revealed a 17% prevalence of insomnia among adults in North America, Latin America, and the Caribbean, and a higher rate of depression in women with OSA

From ResMed Inc.

Via GlobeNewswire

Stryker Stock Sees RS Rating Treks Higher To 71 ↗

May 29, 2024

Stryker stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 63 to 71.

Via Investor's Business Daily

$100 Invested In ResMed 20 Years Ago Would Be Worth This Much Today ↗

May 29, 2024

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.